ABCC2 and familial pancreatic carcinoma: One recent large-scale, multicentre clinical trial showed ABCC2 genetic polymorphisms are associated with worse overall survival in stage I pancreatic cancer, but there is no detailed information regarding the therapies which the patients had received [45].